Seventure Partners, a venture capital firm, and Xora Innovation, an investment company, led a $15m Series A round in Allozymes, an enzyme discovery and engineering company. "We are thrilled to have secured this funding from a distinguished group of investors who share our vision for the transformative potential of enzymes. This investment is a testament to our progress in developing a truly unique and powerful enzyme engineering platform. We are committed to unlocking the full potential of enzymes for a more sustainable and efficient future," Peyman Salehian, Allozymes CEO and Co-Founder.